Early studies have shown that the expression of dopaminergic markers such as tyrosine hydroxylase (TH), dopamine transporter (DAT) and dopamine D2 receptor in the substantia nigra pars compacta and the functional release of dopamine in the striatum are greater in PD rats than controls. This evidence concerns the gene SLC6A3 and Parkinson disease.